Crochan J. O’Sullivan

Showing 1-7 of 7 articles

Interventions for valvular disease

Prognostic impact of invasive haemodynamic measurements in combination with clinical and echocardiographic characteristics on two-year clinical outcomes of patients undergoing transcatheter aortic valve implantation

Franzone A, O’Sullivan C, Stortecky S, Heg D, Lanz J, Vollenbroich R, Praz F, Piccolo R, Asami M, Roost E, Räber L, Valgimigli M, Windecker S, Pilgrim T

April 7, 2017 | 10.4244/EIJ-D-16-00790

Interventions for valvular disease

Effect of resting heart rate on two-year clinical outcomes of high-risk patients with severe symptomatic aortic stenosis undergoing transcatheter aortic valve implantation

O’Sullivan C, Spitzer E, Heg D, Praz F, Stortecky S, Huber C, Carrel T, Pilgrim T, Windecker S

July 20, 2016 | 10.4244/EIJV12I4A83

Impact of B-type natriuretic peptide on short-term clinical outcomes following transcatheter aortic valve implantation

O’Sullivan C, Stortecky S, Heg D, Jüni P, Windecker S, Wenaweser P

February 20, 2015 | 10.4244/EIJV10I10A200

Low-flow, low-gradient aortic stenosis: should TAVI be the default therapeutic option?

O’Sullivan C, Wenaweser P

November 20, 2014 | 10.4244/EIJV10I7A134

Assessment of low-flow, low-gradient, severe aortic stenosis: an invasive evaluation is required for decision making

O’Sullivan C, Praz F, Stortecky S, Windecker S, Wenaweser P

September 27, 2014 | 10.4244/EIJV10SUA9

Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stents

O’Sullivan C, Stefanini G, Räber L, Heg D, Taniwaki M, Kalesan B, Pilgrim T, Zanchin T, Moschovitis A, Büllesfeld L, Khattab A, Meier B, Wenaweser P, Jüni P, Windecker S

January 20, 2014 | 10.4244/EIJV9I9A182

Transcatheter aortic valve implantation: the transfemoral access route is the default access

Stortecky S, O’Sullivan C, Buellesfeld L, Windecker S, Wenaweser P

September 15, 2013 | 10.4244/EIJV9SSA4

1

Latest news

EAPCI/ACVC consensus on pVADs, coronary physiology mini focus, a new analysis from the COAPT trial, patient selection for tricuspid interventions and more…

Joint EAPCI/ACVC expert consensus document on pVADs

Beyond ischaemia: is there a place for physiologic and anatomic evaluations of coronary lesions?

Gilles Montalescot

This Week's JAA's: Principles and Pitfalls in CFT, Brachial access for PCI....

Coronary flow capacity: where to next?

Nils P. Johnson

EuroIntervention's new impact factor!

STATE OF THE ART

Completeness of Revascularisation in ACS Patients with Multivessel Disease

Valeria Paradies et al.

Valvular disease